These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8918605

  • 1. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
    Bellotti V, Merlini G.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
    Buxbaum J.
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
    [Abstract] [Full Text] [Related]

  • 3. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B, Ramirez-Alvarado M, Sikkink L, Golderman S, Dispenzieri A, Livneh A, Gallo G.
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [Abstract] [Full Text] [Related]

  • 4. [Light chain deposition disease].
    Kanoh T.
    Ryoikibetsu Shokogun Shirizu; 1998 Mar; (22 Pt 3):585-7. PubMed ID: 9851224
    [No Abstract] [Full Text] [Related]

  • 5. [Systemic light chain amyloidosis - molecular basis and clinical perspectives].
    Schönland SO, Moos M, Bochtler T, Ho AD, Hegenbart U.
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1949-52. PubMed ID: 19760558
    [No Abstract] [Full Text] [Related]

  • 6. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V, Mangione P, Merlini G.
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P, Plaisier E, Mougenot B, Aucouturier P.
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recurrent light and heavy chain deposition disease after renal transplantation.
    Alchi B, Nishi S, Iguchi S, Shimotori M, Sakatsume M, Ueno M, Narita I, Saito K, Takahashi K, Gejyo F.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1487-91. PubMed ID: 15840680
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis].
    Katayama Y, Sakai A, Nobuyoshi M, Shimomura T, Kimura A.
    Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immunoglobulin amyloidosis].
    Hermine O, Bourquelot P, Buzyn A, Aucouturier P.
    Rev Prat; 1997 Oct 15; 47(16):1787-91. PubMed ID: 9453204
    [Abstract] [Full Text] [Related]

  • 14. Interaction between glycosaminoglycans and immunoglobulin light chains.
    Jiang X, Myatt E, Lykos P, Stevens FJ.
    Biochemistry; 1997 Oct 28; 36(43):13187-94. PubMed ID: 9341206
    [Abstract] [Full Text] [Related]

  • 15. Systemic amyloidoses.
    Blancas-Mejía LM, Ramirez-Alvarado M.
    Annu Rev Biochem; 2013 Oct 28; 82():745-74. PubMed ID: 23451869
    [Abstract] [Full Text] [Related]

  • 16. Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.
    Dalakas MC, Engel WK.
    Trans Am Neurol Assoc; 1979 Oct 28; 104():227-9. PubMed ID: 233329
    [No Abstract] [Full Text] [Related]

  • 17. [Pulmonary diseases and non-amyloid light chain deposition].
    Colombat M, Stern M.
    Rev Mal Respir; 2013 Sep 28; 30(7):524-6. PubMed ID: 24034455
    [No Abstract] [Full Text] [Related]

  • 18. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
    Miyazaki D, Yazaki M, Gono T, Kametani F, Tsuchiya A, Matsuda M, Takenaka Y, Hosh Y, Ikeda S.
    Amyloid; 2008 Jun 28; 15(2):125-8. PubMed ID: 18484339
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains.
    Preud'homme JL, Aucouturier P, Touchard G, Striker L, Khamlichi AA, Rocca A, Denoroy L, Cogné M.
    Kidney Int; 1994 Oct 28; 46(4):965-72. PubMed ID: 7861722
    [No Abstract] [Full Text] [Related]

  • 20. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
    Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G.
    Am J Hematol; 2005 Aug 28; 79(4):319-28. PubMed ID: 16044444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.